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ABSTRACT 
The effect of four doses of dopamine (1o-9M, 10-7M, 
10-5M and 10-3M) and dopamine-receptor agonistic and 
antagonistic agents on renin release and 3' 5' -adenosine 
monophosphate (c-AMP) content of renal cortical tissue 
slices from sodium-deficient rats was studies in vitro. 
Male, Sprague-Dawley rats weighing 210~10 g were fed a 
sodium deficient diet (less than 0.02 mEg/day) for periods 
of time of 2-3 weeks. Following decapitation, renal 
cortical slices weighing 50 ~ 20 mg were prepared using 
a Stadie-Riggs microtome. After a 15 minute preincubation 
period, they were incubated for 1 hr at 37°C in Robinson's 
buffer medium with continuous 95% o2 - 5% C02 gassing, 
in the presence or absence (control) of the pharmacological 
agents. Addition of 10-5M and 10-3M dopamine doses to 
the kidney slice preparation significantly stimulated renin 
release, and the c-AMP content of the renal cortical tissue 
slices was also significantly greater than controls at 
10-3M dopamine concentration. Dopamine doses lower than 
10-5M were ineffective in stimulating either renin release 
or tissue c-AMP content. Addition of the dopamine-receptor 
blocking agent pimozide (10-6M) effectively inhibited the 
stimulatory effect of two dopamine concentrations (10-5M 
ix 
--
and 10-3M) on renin secretion, while significantly 
decreasing tissue c-AMP content levels below those of 
control in slices treated with all four dopamine 
concentrations. Pimozide added alone to the tissue slice 
system signficantly decreased both renin release and tissue 
c-AMP content levels below those seen in control slices. 
The dopamine-receptor agonist apomorphine (1o-6M) added 
to the in vitro slice preparation did not potentiate but 
actually prevented stimulation of renin release by dopamine 
(10-5M and 10-3M), and its action on the c-AMP content 
of slices treated with these two doses of dopamine was 
variable. Apomorphine added alone to the slice system 
did not change either renin release rate or tissue c-AMP 
content. 
These data indicate that: 1) dopamine exerts a 
direct stimulatory effect on renin release which may be 
mediated by a dopmaine-sensitive receptor mechanism 
utilizing c-AMP as the intracellular mediator~ 2) in the 
sodium-deficient state and perhaps under sodium-replete 
conditions, dopamine may participate in the regulation 
of basal renin secretion through changes in intracellular 
c-AMP levels~ and, 3) apomorphine at certain concentrations 
may have both dopamine-receptor agonistic and antagonistic 
properties. 
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CHAPTER I 
INTRODUCTION 
Our knowledge concerning the various mechanisms 
which control renin secretion from the juxtaglomerular 
cells of the kidney has increased at an accelerated pace 
during the last ten years. Davis (1) has classified these 
various factors or mechanisms into three major catagories, 
1) the intrarenal receptors, which refer to the renal 
vascular barorecptors in the renal afferent arteriole 
sensitive to stretch due to changes in perfusing pressure 
(2-6), and the natrioreceptors of the macula densa in the 
distal convoluted tubule sensitive to changes in flux of 
sodium (7-13) or chloride (14-16)~ 2) the humoral factors, 
which include angiotensin II, vasopressin (17, 18), and 
several other factors such as the circulating 
catecholamines, sodium, potassium, calcium ions, and the 
steriod hormones (1)~ and 3) the neural factors which appear 
to exert their regulatory control over renin secretion 
by a direct effect on the juxtaglomerular cells via 
norepinephrine or its precursors released from 
postganglionic sympathetic nerve terminals in the kidney 
(19). Renin release, in most situations, occurs as a result 
of a complex interaction and interplay of these basic 
1 
mechanisms rather than by a preferential activity of any 
these individually. 
It is now clear that the classic intrarenal 
mechanisms (i.e. afferent arteriole barorecptors and macula 
densa natrioreceptors) play a substantial role in the 
control of renin secretion, and that the various other 
humoral and hemodynamic factors are also intimately 
involved. In recent years, however, evidence has 
accumulated pointing to the sympathetic nervous system 
2 
as a very important regulator of renin release, through 
effects which appear to be directly exerted on the 
juxtaglomerular cells by catecholamines released from 
sympathetic nerve terminals. It is interesting to speculate 
that this sympathetic control may turn out to be an 
effective tool for fine regulation of renin secretion 
according to homeostatic needs, and possibly also the 
underlying cause of various pathophysiological alterations 
found in a number of hypertensive conditions. 
In addition to norepinephrine, a catecholamine 
released from renal sympathetic nerve endings, the 
possibility of a direct action of norepinephrine precursors 
such as dopamine on renin secretion has been examined by 
several investigators. In vivo studies by Anton and Sayer 
(20) in 1964, have shown that the kidney contains large 
quantities of dopamine,,although the intrarenal location 
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is not clear. Other in vivo studies (21-23} have presented 
evidence in favor of the existence of specific renal 
dopaminergic receptors, stimulation of which induces 
vascular vasodilation. Additional in vivo (23, 24} and· 
in vitro studies (25) have suggested that these dopaminergic 
receptors may regulate renin release in addition to 
modulating vascular hemodynamics. Further evidence in 
this regard has come from in vitro studies by Henry et 
al (26}, which suggest that dopamine-sensitive receptors 
are present in renal tissue but these receptors are probably 
not dopamine specific. Thus, further experimentation of 
a possible role of dopamine in the regulation of renin 
secretion is clearly in order. Therefore, the purpose 
of the present study is: 1} to evaluate, using an in vitro 
renal cortical slice preparation, a possible direct 
stimulatory effect of dopamine on the renin-secreting 
juxtaglomerular cells of the kidney, when added either 
alone or in conjunction with specific dopamine receptor 
stimulating (apomorphine) or blocking (pimozide} agents; 
2) to examine the possibility of a partial dopaminergic 
control of basal renin secretion, by the addition of 
dopamine-receptor agonistic and antagonistic agents to 
nontreated control samples; 3) to elucidate a possible 
involvement of cyclic-AMP as an intracellular mediator 
of the renin secretory responses to added dopamine and 
other agents; and 4) to evaluate the effect of sodium 
deficiency as a potentiating agent of the renin release 
responses to natural catecholamine precursors, as suggested 
for endogenous catecholamines (norepinephrine). This 
research is important in terms of defining a possible 
contributory role of catecholamine precursors (dopamine) 
released from renal nerve terminals on the minute-to-minute 
control of renin secretion, and would provide additional 
evidence toward characterizing the type of adrenergic 
receptor partly mediating the renin secretory responses 
to sympathetic stimuli. 
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CHAPTER II 
REVIEW OF LITERATURE 
To better understand the factors that affect renin 
secretion, the role of renin as a vital component of the 
renin-angiotensin system must first be reviewed. This 
system, plays a major role in blood pressure control by 
regulating plasma angiotensin II, as well as aldosterone 
synthesis and release. 
A. The Renin-Angiotensin-Aldosterone System 
Renin, a glycoprotein (27, 28), is secreted into 
the systemic circulation from the juxtaglomerular cells 
of the afferent arteriole of the kidney by various 
mechanisms (1, 19, 29, 30). The juxtaglomerular cells 
form part of a larger juxtaglomerular apparatus, which 
also includes the macula densa cells of the distal tubules 
(1). It is the juxtaglomerular cells of this 
juxtaglomerular apparatus that are responsbile for the 
synthesis and release of renin into the afferent arteriole 
of the glomerulus (1, 29). The juxtaglomerular cells are 
modified vascular smooth muscle cells (31) that have evolved 
into endocrine cells. Once renin is released, it 
enzymatically cleaves four amino acids from the carboxyl 
5 
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end of angiotensinogen, a tetradecapeptide plasma alpha 
globulin, which is produced in the liver. The resulting 
decapeptide, angiotensin I, is further hydrolyzed to an 
octopeptide, angiotensin II by a "converting enzyme" (32, 
33) which is present in high concentrations in the pulmonary 
circulation. Angiotensin II is considered to be the most 
potent vasopressor substance in the body (34), and thus 
plays a major role in blood pressure regulation. Davis 
(1), and Laragh (32) also suggest that angiotensin II is 
the major stimulus for the synthesis and secretion of 
aldosterone by the adrenal glornerulosa cells. Vaughan 
et al (35}, however, have recently indicated that the 
primary stimulus for aldosterone biosynthesis is angiotensin 
III, a heptapeptide which is formed by the action of plasma 
and tissue aminopeptidases on the octopeptide angiotensin 
II and perhaps also by hydrolysis of the carboxy-terminal 
end tripeptide of angiotensin I. In turn, aldosterone 
plays a vital role in the regulation of extracellular fluid 
homeostasis. 
B. Factors Regulating Renin Secretion 
As previously indicated, the major interacting 
factors involved in the regulation of renin secretion are 
classified as follows (1}: 1) intrarenal receptors, which 
include the baroreceptors of the afferent arteriole and 
the natrioreceptors of the macula densa in the distal 
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tubule; 2} humoral factors, which include locally generated 
angiotensin II, vasopressin, circulating catecholamines, 
a number of plasma ions and estrogen, among other steroids; 
and, 3} neural factors, which primarily include 
norepinephrine secreted from renal sympathetic nerve endings 
in close association with the juxtaglomerular cells, and 
perhaps catecholamine precursors such as dopamine as well. 
Renal parasympathetic nerve endings appear to play no role 
in the regulation of renin secretion at this time (1}. 
1. Intrarenal Receptors 
a} The Afferent Arteriole Baroreceptor 
Evidence for the presence of a renal vascular 
receptor partially controlling renin release has existed 
for a number of years. Early studies by Kohlsteadt and 
Page (2} on the isolated kidney showed that a decrease 
in blood pressure stimulated renin secretion. It was not 
until 1958, however, that studies by Kolff (3} clearly 
pointed out that renin or a renin-like substance was 
released in response to renal afferent arteriolar 
constriction, independent of pulsatile flow. These 
evidence, added together with his own investigations, 
allowed Tobian (5} to propose the baroreceptor hypothesis 
which postulates that a decreased stretch of the renal 
afferent arteriole as a result of decreased blood pressure 
or blood volume, is sensed by specialized baroreceptor 
cells on the walls of the afferent arteriole near the 
glomerulus, resulting in an increase in renin secretion, 
which will eventually lead to generation of angiotensin 
II and restoration of blood pressure. 
b) The Macu~a Densa Natrioreceptor 
In 1945 a funtional relationship between the macula 
densa cells and-the juxtaglomerular cells was suggested 
by Goormachtigh (7). Macula densa cells are modified 
epithelial cells of the distal convoluted tubules of the 
kidney, which appear sensitive to sodium and/or chloride 
changes (7-16). In 1964, Vander and Miller (8) provided 
the first experimental evidence that the macula densa is 
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an intrarenal sensor. They suggested that a decreased 
sodium load or concentration is sensed by the macula densa 
cells which then convey this message to the juxtaglomerular 
cells to stimulate renin release. Nash et al (9), have 
provided additional evidence for an intrarenal sodium-
sensitive mechanism in the regulation of renin secretion. 
They suggested that the signal for renin release is mediated 
by an altered sodium flux across the macula densa cells. 
However, studies by Burg and Green (14), and Kokko (15), 
have indicated that the macula densa cells respond to a 
chloride load signal, either along with a sodium signal 
or preferentially to a sodium signal. 
2. Humoral Factors 
Among the various humoral factors involved in the 
partial regulation of renin release, angiotensin II and 
vasopressin (ADH) are the most important. However, the 
mechanisms mediating the effects of these two agents on 
renin release are not clear and, moreover, they do not 
appear to play as important a role in regulating renin 
secretion as the intrarenal receptors and neural factors. 
~vivo studies by Shade (18), have shown that intrarenal 
infusion of ADH and angiotensin II inhibit renin secretion. 
Furthermore Bunag et al (36), and Ganong and Lopez (30), 
have confirmed these findings in regard to a possible local 
inhibitory effect of angiotensin II on renin secretion. 
Shade et al (18), have further suggested that angiotensin 
II may exert its inhibitory effect directly on the 
juxtaglomerular cells by a short loop feed-back system 
rather than by an indirect action. This proposed short 
loop feedback system mediating the action of angiotensin 
II on renin release is consistant with evidence provided 
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by the in vivo studies of De Champlain et al (37) in man, 
Vander et al (17) in dogs, and Blair-West et al (38) in 
sheep. Recent studies by Ganong and Lopez (30), have 
additionally suggested that the inhibitory effect of 
angiotensin II on renin secretion may be mediated by a 
decrease in intracellularly generated cyclic 3' 5' adenosine 
monophosphate, which is consistent with a direct action 
of angiotensin II on the juxtaglomerular cells's membranes. 
3. The Renal Sympathetic Nerves and Catecholamines 
a) Juxtaglomerular Apparatus Innervation 
The early studies of De Muylder (39), first 
described a rich nervous system innervation of the renal 
afferent arterioles in the region of the juxtaglomerular 
cells. This initial study was followed by a number of 
light and electronmicroscopic studies (31, 40, 41) which 
confirmed the early observations, and showed the presence 
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of numerous nonmyelinated nerve fibers in close association 
with the renal afferent and efferent arterioles. Subsequent 
electronrnicroscopic (41) and histochemical fluorometric 
studies (42}, have demonstrated the presence of a dense 
network of sympathetic nerve terminals in the region of 
the renal juxtaglomerular cells. In addition, the presence 
of nerve terminals in close proximity to the macula densa 
cells (43) suggests the macula densa is also under neural 
modulation~ but, subsequent fluorometric studies (42}, 
have been unable to confirm this. Recent studies by Muller 
and Barajas {44) have characterized the nerve terminals 
innervating the juxtaglomerular cells as being primarily 
adrenergic in nature with perhaps some cholinergic 
contributions as well. 
b) Effect of Catecholamines on Renin Release 
The morphological evidence regarding the existence 
of a dense sympathetic innervation of the juxtaglomerular 
cells, triggered the undertaking of numerous in vivo (45-
48) and in vitro studies (30, 49-51) designed to evaluate 
the possibility of a direct sympathetic nervous system 
control of renin secretion. These and related data have 
been evaluated in various review papers (1, 19, 29, 52). 
These studies have, for the most part, favored the view 
that catecholamines, specifically epinephrine and 
norepinephrine, stimulate renin release by 1) affecting 
the intrarenal receptors (circulating catecholamines from 
the adrenal medulla) or 2) by a direct stimulatory effect 
exerted on the juxtaglomerular cells themselves by both 
circulating catecholamines and those released from renal 
sympathetic nerve endings in close association with the 
renin-secreting cells. 
The mechanisms by which catecholamines stimulate 
renin secretion have been extensively studied in vivo by 
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a number of investigators (37, 45-48, 53). In one study, 
Johnson et al (48) showed that in the nonfiltering kidney, 
deprived of macula densa effects, the increase in renin 
secretion during intrarenal epinephrine infusion was blocked 
by simultaneous intrarenal papaverine administration, 
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whereas the response to norepinephrine was sustained during 
papaverine infusion. Since these observations were made 
in the nonfiltering kidney with the renal baroreceptor 
blocked by papaverine and a nonfunctional macula densa, 
Johnson et al {48) suggested that the effect of 
norepinephrine was directly exerted on the juxtaglomerular 
cells, whereas the failure of epinephrine to act-during 
papaverine infusion suggests that the renin release 
responses to epinephrine are primarily due to an effect 
of this catecholamine on the renal arteriolar baroreceptors. 
Studies by Vandongen et al {54, 55) have provided further 
evidence suggesting that norepinephrine directly stimulates 
renin secretion, and that renin secretion in response to 
this catecholamine remains increased even when renal 
arteriolar vasoconstriction is blocked with the alpha-
adrenergic blocker phenoxybenzamine. The validity of the 
data from these in vivo studies, can be questioned because 
of the interrelation of the many humoral, hemodynamic and 
neural mechanisms regulating renin secretion all of which 
may participate in the observed responses. Thus, in order 
to evaluate the possibility of a direct regulatory control 
of the sympathetic nervous system on renin release, the 
effects of the various humoral and hemodynamic factors 
on this release must be effectively eliminated by utilizing 
in vitro systems. Utilizing an in vitro dog cell suspension 
system, Mickelakis et al (49) showed that renin secretion 
13 
was increased by both epinephrine and norepinephrine while 
Nelly et al (51) using a rat renal cortical slice 
preparation have produced data suggesting that the 
stimulatory effect of norepinephrine on renin release appear 
to be mediated by a beta-adrenergic receptor on the 
membranes of the juxtaglomerular cells themselves. The 
possibility of a direct stimulatory effect of catecholamines 
on renin secretion has been further supported by numerous 
other in vivo (45-48) and in vitro studies (30, 49-51). 
In vivo studies by Otsuka et al (45) in the dog, 
have shown that the catecholamine-induced renin release 
from the juxtaglomerular cells is potentiated under sodium-
deficient conditions, suggesting an enhanced sensitivity 
of the renin-secreting cells to adrenergic stimuli in the 
sodium-deficient state. This finding, which has been 
supported by others (30, 56) allows an evaluation of 
positive and negative effects of sympathetic stimuli on 
renin secretion. Previous evaluations of sub-control renin 
secretory responses to sympathetic stimuli were difficult 
in view of the already low basal control renin secretion 
levels observed in laboratory animals maintained on 
commercial chow diets which are rich in sodium. Thus, 
when renin secretory levels become significantly lower 
than control levels as a result of the effect of a given 
inhibitory agent, the low responses can not be clearly 
14 
quantitated even by radioimmunoassay. Commercial rat chow 
diets provide approximately 12 times (over 2.2 mEq Na/day) 
the amount of sodium recommended by the National Research 
Council for growing animals, and thus basal renin secretion 
is markedly suppressed. Conversely, animals maintained 
on low sodium diets, receive less than 0.02 mEq of sodium 
per day, and they exhibit a much higher basal renin release 
levels, which is an ideal starting point in the evaluation 
of positive and negative stimulating and inhibitory factors 
which affect renin secretion. More importantly, however, 
is the fact that the sodium-deficient animal exhibits a 
marked potentiation (hypersensitivity) of its renin 
secretory responses to sympathetic stimuli, thus making 
renal sodium-deficient in vitro system an ideal tool for 
evaluation of sympathetic stimuli on renin secretion. 
Utilizing a hypersensitive in vitro renal cortical 
slice preparation from sodium-deficient rats, Ganong and 
Lopez (30) have examined further some of the mechanisms 
by which a variety of sympathetic agents may directly 
regulate renin secretion. Their data are consistent with 
those of Ostuka et al (45) in regard to the potentiation 
of the renin secretory responses to added catecholamines 
in the sodium-deficient animal, and they additionally 
indicate that sodium deficiency enhances the sensitivity 
of the juxtaglomerular cells to sympathetic stimuli. 
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Furthermore, their data (30) suggest that renin secretion 
is mediated by a beta-adrenergic receptor (45-47, 50) 
mechanism mediated by the generation of intracellular cyclic 
AMP, a view that is shared by a number of other 
investigators (30, 50, 51, 57). These data (30) clearly 
show that norepinephrine, in addition to its stimulatory 
effect on renin secretion when added to kidney slices in 
physiological or subphysiological concentrations, also 
exerts an inhibitory effect on renin secretion when added 
in large concentrations. This inhibitory effect of large 
norepinephrine concentrations on renin secretion, appears 
to be mediated by an alpha-adrenergic receptor mechanism 
since the alpha-adrenergic blocking agent phentolamine 
reversed the inhibition. Also, this alpha-inhibitory effect 
appears to be correlated to a significant decrease in c-
AMP generation (30). Additional support for this concept 
has come from the recent in vivo studies of Pettinger (58) 
and the in vitro studies of Capponi and Volloton (59). 
c) Effects of Dopamine on Renin Secretion 
Dopamine is an obligatory precursor in the 
biosynthesis of catecholamines in the brain (60), adrenal 
medulla (61), and sympathetic nerve terminals (62). The 
possibility of a direct action of this catecholamine 
precursor on renin secretion has been examined with 
inconclusive results, primarily because most of the studies 
were done in vivo and other factors could likely have 
contributed to the observed responses. Thus, in vitro 
renal preparations, which effectively remove humoral, 
hemodynamic, and other in vivo influences, clearly need 
to be used as the best alternative tools. The in vivo 
studies of Anton and Sayer (20) have shown that the kidney 
contains large quantities of dopamine, although the source 
whether circulating and/or nerve terminal-secreted is not 
clear. Data from various in vivo (23, 24, 63-65) and in 
vitro (26) investigations have suggested that dopamine 
stimulates renin release, but the mechanisms involved in 
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this release are not clearly defined. Other in vivo studies 
(66) have suggested that dopamine stimulates renin release 
indirectly by stimulating the intrarenal baroreceptors, 
rather than by a direct effect on the juxtaglomerular cells. 
Conversely, Ayers et al (65) found that dopamine infusion 
instead of causing a decrease in renin secretion which 
one may expect as a result of renal arteriolar vasodilation 
actually caused the opposite effect. Goldberg (21) and 
Toda and Goldberg (22) have suggested the existence of 
renal dopaminergic receptors, stimulation of which induces 
renal v'asodilation, but they did not attempt to correlate 
these observations with changes in release rates of renin. 
Further support for the existence of renal dopaminergic 
receptors has come from the in vivo studies of Imbs et 
al (23), in which renal perfusion with haloperidol (specific 
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dopamine-receptor blocker) rather than with propranolol 
(specific beta-adrenergic blocker) suppressed the renin 
hypersecretion induced by dopamine. Recent in vitro studies 
by Nakajima et al (25) have shown that dopamine 
significantly increased the concentration of c-AMP in a 
rat kidney particulate preparation which consisted of 
tubules, glomeruli, and blood vessels. In their work, 
addition of either the alpha-adrenergic blocker, 
phentolamine, or the beta-adrenergic blocker, propranolol, 
failed to significantly reduce the effect of dopamine on 
c-AMP concentration. Conversely the stimulatory effect 
of dopamine on c-AMP was selectively blocked by 
spiroperidol, a dopamine receptor antagonist. In addition, 
Imbs et al (23, 24} and Nakajima et al (25, 67} have data 
further supporting the existence of renal dopaminergic 
receptors which appear to differ from renal beta-adrenergic 
receptors, and which behave in a manner similar to that 
of the intrarenal receptors, thereby indirectly regulating 
renin secretion. In contrast, in vitro studies by Henry 
et al (26) suggest that dopamine-sensitive receptors may 
be located on the membranes of the juxtaglomerular cells 
themselves, but these receptors may not be specific for 
dopamine alone but rather of the beta-type, capable of 
binding norepinephrine and the other catecholamines as 
well. 
In view of the importance of dopamine as a central 
neurotransmitter, and the fact that the kidney appears 
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to contain large amounts of this catecholamine precursor, 
further studies are clearly in order to examine a possible 
regulatory role of this compound on renin secretion. Thus, 
a series of studies were designed to evaluate such a role, 
by examining a possible direct effect of dopamine on renin 
release, as well as the possibility that c-AMP may be 
involved as a mediator in this process. In addition the 
effects of specific dopamine-receptor agonistic and 
antagonistic agents are used to further characterize the 
type of receptors mediating the renin secretory responses 
to dopamine. 
CHAPTER III 
MATERIALS AND METHODS 
Twenty-four male, Sprague-Dawley rats (Sprague 
Dawley Co. Madison, Wisconsin) with initial weights of 
210 ~ 10 grams were fed a sodium-deficient diet (Teklad 
Test Diets, Madison, Wisconsin) which provided less than 
0.02 milliequivalents of sodium per day, for periods of 
time of 2-3 weeks. The rats were kept two animals per 
cage, in a temperature-controlled room (23 ~ 2°C), with 
a 12 hr light/12 hr dark photoperiod, and had access to 
distilled, deionized water ad libitum. After 2-3 weeks 
on this diet the animals were sacrificed by decapitation 
and their kidneys were rapidly excised, decapsulated, and 
gassed with a mixture of 95% oxygen-5% carbon dioxide for 
30 seconds, while being maintained in Robinson's buffer 
medium at 4°C (68). Slices of renal cortex approximately 
0.3 millimeters thick and weighing 50 ~ 20 milligrams were 
subsequently prepared using a Stadie-Riggs microtome (A. 
Thomas, Co.). Each cortical slice was divided into six 
similar portions which were randomly assigned to six 
separate incubating vessels containing 2.5 ml of Robinson's 
buffer. The procedure was repeated using slices from other 
areas of the renal cortex until each vessel contained 50 
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~ 20 milligrams of renal cortical tissue. This tissue 
distribution insured a homogeneous population of renal 
cortical cells in each incubating vessel. The slices were 
then pre-incubated for 15 minutes at 37°C in a shaking 
Dubnoff Metabolic Incubator (Precision Scientific Co.), 
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in an atmosphere saturated with 95% oxygen-5% carbon 
dioxide. The pre-incubated slices were subsequently 
transferred to similarly numbered vessels containing fresh 
Robinson's buffer maintained at 37°C and were then incubated 
for one hour under conditions identical to those during 
pre-incubation. One of each group of six vessels served 
as a nontreated control, while the other five vessels 
received respectively, one of various dopamine doses (Sigma 
Chemical Co.) ranging from lo-9 Molar to lo-3 Molar, which 
were added either alone or in conjunction with the dopamine-
receptor agonist agent apomorphine (10-6M) or the dopamine-
receptor blocking agent pimozide (1o-6M). Apomorphine 
(1o-6M) and pimozide (1o-6M) were also added alone to the 
remaining vessels. Both agonistic and antagonistic agents 
were added to the slice preparation before the pre-
incubation as well as incubation periods, whereas dopamine 
was only added at the begining of the incubation period. 
Dopamine and apomorphine solutions were prepared in 0.1% 
ascorbic acid (Sigma Chemical Co.) to prevent oxidation 
of the catecholamine and the dopamine-receptor agonist. 
(Free, Lopez, Ganong, unpublished observations). Pimozide 
was prepared in 0.1% tartaric acid (Janssen Pharaceutica) 
which also prevented oxidation of the dopamine-receptor 
antagonist agent. After incubation, the incubated 
supernatant medium was collected in 12 X 75 mm tubes 
(Scientific Products) and stored at -20°C until assayed 
for renin concentration by radioimmunoassay (RIA) of 
angiotensin I (Squibb). The slices were rapidly frozen 
on dry ice and subsequently homogenated in 1 ml of 8% 
trichloroacetic acid (TCA). Homogenates were then 
transfered to 12 X 75 mm tubes containing 5 drops of 0.1 
N HCl, vortexed, and immediately centrifuged at 4000 rpm 
for 10 min at 4°C. The protein-containing precipitate 
was discarded and the supernatant was trasfered to conical 
centrifuge tubes using Pasteur pipets. The samples were 
then washed 4 times with water-saturated ether 
(Mallinckrodt), vortexed for 10 sec each time, and the 
upper, ether-containing phase, aspirated using Pasteur 
pipets and discarded after each wash. In turn, the lower, 
c-AMP-containing water phase, was decanted after each wash 
into appropriate glass vials which had been set on dry 
ice for immediate freezing. The frozen vials containing 
the water-soluble c-AMP were subsequently lyophyllized 
(Virtix lyophyllizer) for 4-5 hours to remove the water. 
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The freeze-dried cyclic AMP was then stored at -20°C until 
assayed by a modification of the competitive protein binding 
assay of Gilman (69). 
A. Renin Concentration Determination of Radioimmunoassay 
of Angiotensin I 
1. Angiotensin I Generation 
Since purified renin is not available, there is 
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no direct radioimmunoassay of renin. In order to determine 
renin concentration, a method has been developed for the 
estimation of renin concentration through the 
radioimmunoassay of angiotensin I generated by the action 
of renin on incubated supernatant samples in the presence 
of renin substrate (angiotensinogen). To generate 
angiotensin I, the frozen incubated supernatant samples 
which had been kept at -20°C were allowed to thaw at room 
temperature and subsequently maintained at 4°C in an ice-
water bath. Defrosted supernatant samples were vortexed 
for 15 seconds and 0.025 ml aliquots of each unknown were 
transfered to labeled 12 X 75 mm pyrex tubes also kept 
at 4°C. To each tube, l ml of 24-hr nephrectomized dog 
plasma, which has been dialyzed against phosophate-EDTA 
buffer was added. Prior to its addition to the incubated 
supernatant samples, the 1 ml nephrectomized dog plasma 
aliquots containing endogenous renin substrate 
(angiotensinogen) were treated with 0.05 ml of a 1% solution 
of phen~lmethysulfonealfluride (Sigma Chemical Co.) an 
inhibitor of plasma converting enzyme and other plasma 
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angiotensinases, to prevent degradation of generated 
angiotensin I or conversion of angiotensin I to angiotensin 
II. The inhibitor-treated nephrectomized dog plasma 
aliquots were then adjusted to a pH of 5.4 - 5.7 with 1% 
HCl to insure an optimium renin enzymatic activity. The 
unknown supernatant samples tq which the nephrectomized 
plasma substrate had been added, were then incubated in 
a water bath at 37°C for two hours to allow generation 
of angiotensin I. Following this 2-hr generation period, 
the samples were removed from the water bath and 1 ml of 
distilled, deionized water was added. The angiontensin 
I containing samples were then vortexed, covered with 
aluminum foil to prevent evaporation, and immersed in 
boiling water for 2-3 minutes, to stop any further reaction 
by precipitation of most proteins except angiotensin I 
which is heat stable. At the end of the boiling period, 
the angiotensin I containing samples were allowed to cool, 
covered with parafilm (Fischer Co.), and stored at -20°C 
until assayed for angiotensin I content by radioimmunoassay. 
2. Radioimmunoassay Procedure of Angiotensin I 
Renin concentration was determined by RIA of 
angiotensin I utilizing materials purchased from the Squibb 
Co. (Rolling Meadows). This procedure used a specific 
antibody for angiotensin I 125Iodine-labeled angiotensin 
I as the radioactive tracer and synthetic angiotensin I 
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as a reference standard. Duplicate unknown sample aliquots 
used for the RIA procedure were either 0.025 ml, 0.05 ml 
or 0.1 ml depending on the concentration of angiotensin 
I present in the samples. Following charcoal separation, 
the samples were centrifuged at 4500 rpm for 10 min at 
4°C using a sorvall RC2-B refrigerated centrifuge and the 
supernatant decanted into 12 X 75 mm tubes for counting. 
Counting time was 1 minute. The various steps in this 
RIA procedure have been outlined in detail (Squibb). 
B. Determination of Cyclic 3' 5' Adenosine Monophosphate 
(c-AMP) By Competitive Protein Binding Assay 
Freeze-dried c-AMP samples obtained after 
lyophylization, were reconstituted with 0.25 ml of 4 mM 
Tris/EDTA buffer pH 7.5 (Amersham). Duplicate 0.05 ml 
aliquots of the reconstituted unknown samples were mixed 
in 12 X 75 mm tubes with 0.10 ml of binding-protein, and 
0.05 ml of 3H-labeled c-AMP, to a total assay volume of 
0.2 ml. C-AMP standards were prepared similarly. The 
samples were vortexed for 15 seconds and then allowed to 
incubate at 4°C for 90 minutes. At that time, 0.2 ml of 
a charcoal suspension (Amersham) were added to the cold-
incubated samples to separate protein-bound from free c-
AMP, the samples were vortexed for 5 seconds and immediately 
centrifuged at 4°C for 10 minutes at 3500 rpm. 0.2 ml 
of the supernatant were subsequently counted in a tri-carb 
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liquid sintillation spectrophotometer. 
C. Statistical Calculations 
Statistical significance of the c-AMP content and 
renin secretion was evaluated by a modified paired student's 
"t" test (70} using a programable desk top calculator 
(Hewlett-Packard, 1900B}. 
CHAPTER IV 
RESULTS 
In an initial study, the effect of dietary sodium 
changes on basal renin release and cyclic-AMP content of 
rat renal cortical slices was evaluated. These data can 
be seen in figure 1. As observed in this figure, the basal, 
non-stimulated, renin release rate in slices from sodium-
deficient rats was significantly greater (P < 0.01) when 
compared to that seen in the sodium-replete animals. In 
turn, the cyclic-AMP content of slices from sodium-deficient 
rats was not significantly different from that of slices 
from the sodium-replete group of animals (figure 1). 
Based upon the data obtained from the preliminary 
study, a renal cortical slice system prepared from sodium-
deficient rats was utilized in all subsequent studies. 
Figure 2 depicts the changes in renin release in slices 
from sodium-deficient rats in response to various 
concentrations (10-9M, 10-7M, 10-sM, and 1o-3M) of dopamine 
hydrochloride. As shown in this figure, dopamine doses 
of 10-9M and 10-7M were ineffective in stimulating renin 
secretion. Conversely, higher concentrations of this 
catecholamine (10-SM and 10-3M), significantly stimulated 
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FIGURE 1 
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Legend: 
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Figure r.'· · 
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• Changes in renin release and cyclic AMP content 
in re·nal cortical slices from sodium-deficient rats compared 
to rats maintained on a sodium-replete diet (control). c 
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Figure. 2: • . ·· 
•, 
.. 
£f~ect of various concentrations of dopamine 
• hydrochloride on renin release by renal cortical slices 
from sodium-deficient rats. The data represents the mean 
•I 
renin release change ~ s. E. of 12 observations (number 
of slice pairs) for each dopamine concentrations. The 
mean control (non-stimulated) rate of renin release was 
5.43 ~ 0.19 ng/mg/hr during a 60 minutes incubation period. •I 
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renin release, with the highest mean renin release values 
seen at a dopamine concentration of 10-sM. However, a 
statistical comparison between the two stimulatory 
concentrations of dopamine showed no significant differences 
between them with respect to stimulation of renin secretion. 
When their stimulatory effects on renin release were 
compared to those exerted by lower dopamine doses (1o-9M 
and 1o-7M) a dose-response relationship was clear. Thus, 
these data (figure 2) indicate that threshold for maximal 
stimulation of renin release was reached with a dopamine 
concentration of 10-SM, and that higher doses of this 
catecholamine were ineffective in further potentiating 
the renin secretory rate. 
When the renin secretory responses to various 
dopamine doses (figure 2) are compared to those in c-AMP 
content in response to the same dopamine concentrations 
(figure 3) a partial correlation can be observed. These 
data (figure 3) show that at a concentration of 1o-3M, 
dopamine significantly stimulated both renin release and 
c-AMP content in cortical slices from sodium-deficient 
rats. At 10-sM, however, dopamine significantly stimulated 
renin release, but did not affect c-AMP content. Dopamine 
concentrations of 10-7M and 10-9M did not change c-AMP 
content from that of controls, which is consistent with 
the changes seen in renin secretion in response to the 
FIGURE 3 
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Legend: .. 
.. 
Effect of various concentrations of dopamine 
hydro~hloride on renin release and c-AMP content of renal 
cortical slices from sodium deficient rats. The data 
represents the mean renin release change ~ s. E. and the 
mean c-AMP content change ~ s. E. respectively, of 12 
observations (number of slice pairs) for each dopamine 
concentration. The mean control (non-treated) rata of 
renin release was 5.43 ~ 0.19 ng/mg/hr and the mean control 
c-AMP content was 0.42 ~ 0.02 pmol/mg wet tissue, 
respectively. Incubation time was 60 minutes. 
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same doses of this catecholamine (figure 3). As seen with 
the renin secretory responses to the four dopamine 
concentrations, a dose-response relationship is also 
apparent in regard to the c-AMP content changes (figure 
3 ) • 
Data from a subsequent study designed to evaluate 
the possibility of a specific dopaminergic-receptor 
mechanism mediating the renin release and c-AMP content 
responses to added dopamine are shown in figure 4. This 
figure illustrates the renin secretory changes seen in 
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renal cortical slices from sodium-deficient rats in response 
to four dopamine doses (1o-9M, 1o-7M, 1o-5M and 1o-3M), 
added either alone or in conjunction with a dopamine-
receptor blocking agent, pimozide (1o-6M). As observed 
(figure 4), when added together with two dopamine doses 
(1o-9M and 1o-7M), which by themselves were ineffective 
in stimulating renin release, pimozide did not affect the 
renin release responses observed with dopamine alone 
although it did depress the mean renin release rates. 
Conversely, when added in conjunction with higher dopamine 
doses (10-5M and 10-3M) pimozide effectively prevented 
the significant stimulatory effect of these dopamine 
concentration on renin release. Furthermore, addition 
of pimozide alone to the renal cortical slice preparation 
significantly decreased renin secretion in relation to 
FIGURE 4 
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Figure 4'· . 
Changes in renin release in response to various 
dopamine hydrochloride concentrations, added either alone 
or together with 1o-6M pimozide to renal cortical slices 
of rats fed a sodium-deficient diet for 2-3 weeks. The 
data represents the mean renin release change = S. E. of 
12 observations (number of slice pairs) for each dopamine 
concentration added alone, and 7-10 observations for each 
dopamine concentration added together with pimozide. The 
mean control (non-stimulated) rate of renin release was 
5.43 = 0.19 ng/mg/hr during a 60 minute incubation period. 
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the non-stimulated control samples. 
When the renin release data on figure 4 are compared 
to those in c-AMP content in response to the same four 
doses of dopamine plus pimozide (figure 5), a clear 
correlation between renin release and c-AMP content changes 
can be observed. The inhibitory effect of pimozide was 
particularly striking in regard to cyclic-AMP content since 
it not only prevented the significant stimulatory effect 
of 10-3M dopamine on c-AMP content but it significantly 
decreased the c-AMP content levels of tissue slices treated 
with all four dopamine doses to values far below those 
of non-treated control slices. Pimozide added alone 
significantly decreased both renin release as well as the 
c-AMP content of the tissue slices in relation to the non-
stimulated control samples. 
Table 1 illustrates the results of an additional 
study designed to evaluate the effect of the dopaminergic 
receptor agonist apomorphine (10-6M), on the renin release 
and c-AMP content responses to four dopamine doses (1o-9M, 
10-7M, 10-5M and 10-3M) in renal cortical slices from sodium-
deficient rats. As opposed to pimozide, when added alone 
the slice preparation, apomorphine did not alter renin 
secretion or c-AMP content levels in relation to those 
of controls. However, it did prevent the stimulatory effect 
of 10-SM and 10-3M dopamine concentrations on renin release 
I 
I' 
II 
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FIGURE 5 
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Legend: ·. · 
• Changes in renin release and c-AMP content in 
resporise to various concentrations of dopamine 
hydrochloride, added either alone or together with 1o-6M 
pimozide to renal cortical slices of rats fed a sodium-
deficient diet for 2-3 weeks. The data represents the 
mean renin release change ~ s. E. and the mean c-AMP content 
change~ s. E., respectively, of 12 observations (number 
of slice pairs) for each dopamine concentration added 
together with pimozide. The mean control (non-treated) 
rate of renin release was 5.43 ~ 0.19 ng/mg/hr. The mean 
control c-AMP content •as 0.42 ~ 0.02 pmol/mg wet tissue. 
Incubation time was 60 minutes. 
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Changes in • 
renin release 
ng/mg/hr 
from control 
P value 
N value 
Changes in • 
c-AMP content 
Pmole/Mg/wet 
tissue 
from control 
from control 
P value 
N Value 
-3 5 -7 -9 Effect of various doses of dopamine (10 M, 10- M, 10 M, and 10 M) in the presence and absence of 
apomorphine (10-6M) on Renin secretion and c-AMP content on renal cortical slices from sodium deficient 
rats. 
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when added in conjunction with the catecholamine. 
Furthermore, apomorphine prevented the significant 
stimulatory effect of 10-3M dopamine on c-AMP content 
although when compared to each other (1o-3M dopamine alone 
vs. 1o-3M dopamine plus apomorphine) there was no 
significant difference in the effect of both treatments 
on c-AMP content. Apomorphine did, however, potentiate 
the c-AMP content responses of renal cortical slices to 
10-5M dopamine, but again, comparison of the two values 
(10-SM dopamine alone vs. 10-SM dopamine plus apomorphine) 
showed no significant statistical differences. From these 
data (table 1) it is clear that at no time apomorphine 
potentiated the effects of any of the stimulatory dopamine 
doses on renin release and in fact it prevented the 
stimulation seen with 1o-5M and 10-3M dopamine doses added 
alone to the slice preparation. 
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CHAPTER V 
DISCUSSION 
Studies utilizing in vitro kidney preparations 
(30, 49-51, 71} have provided evidence supporting the 
concept of a direct stimulatory effect of catecholamines 
on the juxtaglomerular cells of the kidney to affect renin 
release. In these preparations, the influence of various 
humoral, hemodynamic, and other factors which are known 
to influence renin release in the intact animal are 
eliminated, and although the various cell types are still 
present in the in vitro preparations, the effects of added 
catecholamines on renin release are most likely due to 
a direct effect on the renin-secreting cells. Furthermore, 
there is in vivo (45, 56) and in vitro (30, 72) evidence 
which indicates that sodium deficiency not only potentiates 
the renin secretory responses to sympathetic stimuli; but 
that it causes a chronic hypersecretion of renin resulting 
in elevated basal renin release levels (30, 72}. 
Thus, in an initial study utilizing as in vitro 
rat renal cortical slice preparation we evaluated the effect 
of dietary sodium changes on renin release and c-AMP content 
of kidney slices from animals which had been fed either 
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sodium-deficient or sodium-replete diets for 2-3 weeks. 
The results from this initial study (figure 1) confirmed 
previous findings (30, 72) indicating that the basal, non-
stimulated renin release rate in renal cortical slices 
from sodium-deficient rats is significantly greater than 
that seen in slices from sodium-replete animals. 
Surprisingly, however, c-AMP content levels in slices from 
both sodium-deficient and sodium-replete rats were not 
different statistically, suggesting that the increased 
renin release rate seen in sodium-deficient animals may 
not involve changes in the intracellular concentration 
of this nucleotide. There are no previous data in this 
regard to allow for a comparison of our results on c-AMP 
content changes in response to dietary sodium manipulation. 
In a subsequent study (figures 2 and 3) the effect 
of various concentrations of dopamine hydrochloride on 
renin release and c-AMP content in renal cortical slices 
from sodium-deficient rats was evaluated. As shown in 
these figures~ two concentrations of dopamine (10-SM and 
10-3M) significantly stimulated renin release, with 
threshold for a maximal renin secretory rate being observed 
at a dopamine concentration of lo-SM. Conversely, lower 
dopamine concentrations (1o-9M and 10-7M) were ineffective 
in stimulating renin release. The results seen with the 
stimulatory concentrations of dopamine are consistent with 
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previous in vivo (23, 24, 63-65) and in vitro (26) 
observations which suggest that renin release may partially 
be under dopaminergic control. However, most of these 
studies above have not attempted to postulate a possible 
mechanism or mechanisms mediating the stimulatory action 
of dopamine or renin secretion. The in vitro renin release 
data (figures 2 and 3), on the other hand, suggest that 
the stimulatory effect of dopamine on renin release may 
be a direct one on the juxtaglomerular cells, a postulation 
which is in agreement with some (26). In partial support 
of this view are the data obtained in these studies (figure 
3) in regard to the c-AMP content changes seen in kidney 
slices in response to the highesi concentration of added 
dopamine (10-3M) examined. The fact that both renin release 
rate and c-AMP content levels were significantly increased 
in response to this dopamine dose, clearly supports the 
possibility that dopamine may stimulate renin secretion 
by interacting with a membrane receptor which utilizes 
c-AMP as the intracellular mediator. Furthermore, even 
when the tissue c-AMP content levels were not significantly 
elevated in response to other dopamine doses (figure 3), 
they nevertheless paralleled at all times the changes seen 
in renin secretion in response to the same dopamine 
concentrations, further supporting a c-AMP-mediating action. 
It has been postulated that stimulation of renin release 
by other catecholamines is mediated by an increased 
intracellular c-AMP generation and that dopamine may exert 
its action on renin secretion in a similar manner (25}. 
The renin release and tissue c-AMP content data (figures 
2 and 3} are consistent with this view, but do not clarify 
whether the membrane adenylate cyclase receptor complex 
activates by dopamine is specific for this catecholamine 
or whether it is of the beta-type which is responsive to 
all catecholamines as proposed by some investigators (26}. 
45 
To further explore the possibility of a dopamine-
specific receptor complex mediating the action of this 
catecholamine on the juxtaglomerular cells, changes in 
renin release and c-AMP content of renal cortical slices 
from sodium-deficient rats in response to various dopamine 
doses added either alone or in conjunction with a specific 
dopamine-receptor blocking agent pimozide (1Q-6M) studied 
(figures 4 and 5). Addition of pimozide to the kidney 
slice system not only prevented the significant stimulatory 
effect of two dopamine doses (1o-5M and 1o-3M} but it 
significantly inhibited the basal renin secretion of the 
tissue slices when added alone (figures 4 and 5). 
Similarly, pimozide significantly decreased renal cortical 
tissue slice c-AMP content when added alone or in 
conjunction with all dopamine concentrations utilized 
(figure 5}. Numerous studies (21-25} have proposed the 
existence of specific dopaminergic receptors, but other 
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(26) have indicated that these dopamine-sensitive receptors 
may not be specific for dopamine alone but rather of the 
the beta type, capable of binding other catecholamines 
as well. These data (figures 4 and 5) support the concept 
that stimulation of renin release by dopamine is mediated 
by an increased intracellular c-AMP generation via a 
specific dopamine receptor mechanism. This view is shared 
by other investigators (25) but in their studies no attempt 
was made to measure renin release and c-AMP content changes 
simultaneously. Thus, the results obtained as a result 
of simultaneous evaluation of renin release and c-AMP 
content changes in these studies provide strong support 
for the existence of a specific dopamine-receptor mechanism 
mediating the action of this catecholamine on renin 
secretion. Furthermore, the significant inhibition seen 
in renin release and c-AMP content of slices treated with 
pimozide alone (figure 5~, suggests that endogenous dopamine 
exerts a partial regulatory control over the basal renin 
secretory levels in the intact animal, and that this control 
may be mediated by intracellular c-AMP changes. The 
significance of this is not clear, but these observations 
certainly indicate that not only norepinephrine released 
from renal nerve endings but also dopamine, perhaps from 
the same source, may work in conjunction to modulate the 
minute-to-minute basal renin secretory rate in vivo. An 
alternative possibility may be proposed in view of the 
fact that the basal renin release rate in the sodium-
deficient animal is significantly greater than that seen 
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in animals fed commercial chow diets. It is possible that 
the renin hypersecretion seen in sodium-deficient animals 
is the one under a partial dopaminergic control and that 
the basal renin secretory levels observed in sodium-replete 
animals are under a difference type of control. Obviously, 
studies utilizing pimozide in slices from sodium-replete 
rats are clearly needed to evaluate this possibility and 
they are presently being conducted in our laboratory. 
Potentiation of the stimulatory effects of two 
dopamine doses (10-SM and 10-3M) on renin secretion, by 
the simultaneous addition of a dopmaine-receptor agonist 
apomorphine (10-6M), was not observed in these studies 
as the concentration of apomorphine utilized (table 1). 
In fact, apomorphine actually prevented the stimulatory 
effect of dopamine (lo-SM and 1o-3M) on renin release. 
Although these results appear contradictory to what one 
may expect from the postulated action of apomorphine, they 
are nevertheless in agreement with another study (71) which 
has suggested that apomorphine at certain concentrations 
is antagonistic to dopamine action. The effect of 
apomorphine on tissue c-AMP content in our studies was 
not clear. It did inhibit the increase in c-AMP content 
seen in slices treated with 1o-3M dopamine, but it 
significantly stimulated c-AMP content of slices treated 
with 10-5M dopamine. These observations suggest that, 
whether stimulatory or inhibitory, the mechanism action 
of apomorphine on dopamine receptors may be independent 
of c-AMP changes. Further studies are clearly needed in 
this regard. 
In summary, the data discussed in this thesis 
confirm previous observations which have been shown that 
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the basal, non-stimulated renin release rate in renal 
cortical slices from sodium-deficient rats is significatnly 
greater than that seen in sodium-replete animals. These 
data also indicate that dopamine exerts a direct stimulatory 
effect on renin release which appears to be mediated by 
a dopamine-sensitive receptor mechanism utilizing c-AMP 
as the intracellular mediator. Furthermore, the effect 
of dopamine on renin secretion and c-AMP content of slices 
from sodium-deficient rats appears to be concentrations 
dependent, ruling out leakage from the cells as a 
contributing factor in the results observed. Additionaly, 
these results suggest that dopamine may be an important 
endogenous modulator of the basal renin secretion seen 
in non-stimulated, sodium-deficient juxtaglomerular cells, 
although similar results in slices from sodium-replete 
animals are needed to further support this view. Finally, 
these data are inconclusive as to the actual effects exerted 
by apomorphine on renin release and tissue c-AMP content, 
and additional doses of this dopamine-receptor agonistic 
agent clearly need to be evaluated. 
49 
The data presented in this paper constitute 
additional evidence supporting the concept that the 
sympathetic nervous system exerts a direct regulatory 
control over the secretion of renin from the juxtaglomerular 
cells of the mammalian kidney, and support the view that 
dopamine-sensitive receptor mechanisms may participate 
in this control. 
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APPENDIX A 
1. Radioimmunoassay Calculations 
To correct for dilution of the initial unknown 
sample aliquot (0.025) throughout the generation procedure 
and subsequent RIA, as well as to convert the RIA values 
expressed as picograms of A-1 to the final values in 
nanograms of angiotensin I/mg wet tissue/hr, which is the 
conventional way of expressing renin concentration, the 
following formula was employed: 
Renin 
Concentration = pg of A-I X 40 X 2 X (40, 20, or 10) X 2.5 
expressed as 2 X loa 
ng A-I/rng wet tissue/hr mg wet tissue 
In numerator: 
pg of A-I = picograms of angiotensin I determined 
for unknown samples by reading off 
the RIA standard curve for angiotensin I 
40 = a factor obtained by diluting the 
initial 0.025 ml of incubated 
supernatant with 1 ml of 24-hr 
nephrectomized dog plasma plus 
inhibitor 
2 = a factor obtained by diluting 1 ml 
of generated sample with 1 ml of 
distilled, deionized water following 
a 2-hr generation of angiotensin I 
40, 20, or 10 = a factor which depends on the 
unknown generated sample aliquot 
size (0.025 ml, 0.05 ml, 0.1 ml} 
used for the RIA procedure, 
when diluted to a final assay 
volume of 1 ml 
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2.5 
In denominator: 
2 
1000 
mg 
= 
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a factor which represents the original 
volume of Robinson's buffer that was 
used to incubate the renal cortical 
tissue. 
= a factor which converts the 2-hr 
generation time of angiotensin 
I to 1 hr. 
= a factor which converts picograms 
of angiotensin I to nanograms 
angiotensin I. 
= milligrams of wet renal tissue weight. 
This factor converts nanograms 
angiotensin I per hour to nanograms 
angiotensin I per hour Per milligrams 
wet renal tissue weight. 
2. Cyclic AMP Calculations 
Since only 0.050 ml aliquots of the total 0.25 
ml volume of tris/EDTA reconstituted unknown samples was 
utilized for the CPB assay, the value for the unknown, 
expressed as picograms of c-AMP were corrected for this 
by a 5.0 multiplication factor. Additionally, the final 
results were corrected for the wet tissue weight of the 
samples and expressed as picograms c-AMP per mg wet tissue. 
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